General Psychiatry (Jun 2020)
Expert consensus on the prevention and treatment of substance use and addictive behaviour-related disorders during the COVID-19 pandemic
- Jing Li,
- Jiang Du,
- Lin Lu,
- Wei Hao,
- Min Zhao,
- Jie Shi,
- Yi Li,
- Mei Yang,
- Tieqiao Liu,
- Bing Li,
- Na Zhong,
- Fen Liu,
- Mincai Qian,
- Yu-Ping Ning,
- Yan Xia,
- Haifeng Jiang,
- Wei Yuan,
- Xuhui Zhou,
- Ni Fan,
- Xiaochang Lan,
- Shichao Xu,
- Hongxian Chen,
- Xiaojun Xiang,
- Xuyi Wang,
- Hongqiang Sun,
- Wanjun Guo,
- Yajuan Niu,
- Lixia Sheng,
- Xuebin Liu,
- Wenhua Zhou,
- Ruiling Zhang,
- Hongxing Hu,
- Zhonghua Su,
- Ruimin Zhang
Affiliations
- Jing Li
- Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China
- Jiang Du
- Drug Abuse Treatment Department, Shanghai Mental Health Center, Shanghai, China
- Lin Lu
- Peking University Sixth Hospital, Beijing, China
- Wei Hao
- Mental Health Institute, Second Xiangya Hospital, Central South University, Changsha, Hunan, China
- Min Zhao
- lecturer of nutritional epidemiology
- Jie Shi
- Peking University School of Basic Medical Sciences, Beijing, China
- Yi Li
- Drug Abuse Treatment Department, Wuhan Mental Health Center, Wuhan, Hubei, China
- Mei Yang
- Drug Abuse Treatment Department, Shenzhen Kangning Hospital, Shenzhen, Guangdong, China
- Tieqiao Liu
- Mental Health Institute, Second Xiangya Hospital, Changsha, Hunan, China
- Bing Li
- Peking University Sixth Hospital, Beijing, China
- Na Zhong
- Drug Abuse Treatment Department, Shanghai Mental Health Center, Shanghai, China
- Fen Liu
- Drug Abuse Treatment Department, Shenzhen Kangning Hospital, Shenzhen, Guangdong, China
- Mincai Qian
- Huzhou Third People's Hospital, Huzhou, Zhejiang, China
- Yu-Ping Ning
- The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China
- Yan Xia
- Mental Health Department, First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China
- Haifeng Jiang
- Shanghai Mental Health Center, Shanghai Jiao Tong University, Shanghai, China
- Wei Yuan
- Drug Development Unit, Royal Marsden Hospital/ Institute of Cancer Research, Sutton, UK
- Xuhui Zhou
- 1 Department of Orthopedics, Changzheng hospital, Second Military Medical University, Shanghai, China
- Ni Fan
- Drug Abuse Treatment Department, Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
- Xiaochang Lan
- Drug Abuse Treatment Department, Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
- Shichao Xu
- Drug Abuse Treatment Department, Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
- Hongxian Chen
- Mental Health Institute, Second Xiangya Hospital, Changsha, Hunan, China
- Xiaojun Xiang
- Mental Health Institute, Second Xiangya Hospital, Changsha, Hunan, China
- Xuyi Wang
- Mental Health Institute, Second Xiangya Hospital, Changsha, Hunan, China
- Hongqiang Sun
- Peking University Sixth Hospital, Beijing, China
- Wanjun Guo
- Mental Health Institute, Sichuan University West China Hospital, Chengdu, Sichuan, China
- Yajuan Niu
- Drug Abuse Treatment Department, Beijing Huilongguan Hospital, Beijing, China
- Lixia Sheng
- Drug Abuse Treatment Department, Beijing An Ding Hospital, Beijing, China
- Xuebin Liu
- Drug Abuse Treatment Department, Wuhan Mental Health Center, Wuhan, Hubei, China
- Wenhua Zhou
- Drug Abuse Treatment Department, Ningbo University Medical School, Ningbo, Zhejiang, China
- Ruiling Zhang
- Drug Abuse Treatment Department, Xinxiang Medical University Affiliated Second Hospital, Xinxiang, Henan, China
- Hongxing Hu
- Xinjiang Medical University Affiliated First Hospital, Urumqi, Xinjiang, China
- Zhonghua Su
- Mental Health Department, Shandong Province Ankang Hospital, Jining, Shandong, China
- Ruimin Zhang
- Huayou Health Care Center, Beijing, China
- DOI
- https://doi.org/10.1136/gpsych-2020-100252
- Journal volume & issue
-
Vol. 33,
no. 4
Abstract
No abstracts available.
